Systemic mastocytosis and other mast cell neoplasms

British Journal of Haematology

Volumn 106, Issue 1, 1999, Pages 9-17

  Bain, Barbara J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Cytogenetics; Mast cell leukaemia; Myeloproliferative disorders; Oncogenes (c kit); Systemic mastocytosis

Indexed keywords

CANCER CLASSIFICATION; CANCER SURVIVAL; HUMAN; MAST CELL; MAST CELL LEUKEMIA; PRIORITY JOURNAL; REVIEW; SYSTEMIC MASTOCYTOSIS;

HUMANS; MASTOCYTOSIS; SKIN NEOPLASMS;

EID: 0032816766     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01458.x     Document Type: Review

References (63)

1. Agis, H., Beil, W.J., Bankl, H.C., Füreder, W., Sperr, W.R., Ghannadan, M., Baghestanian, M., Sillaber, C., Bettelheim, P., Lechner, K. & Valent, P. (1996) Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myclodysplastic syndrome: diagnostic rate of cell-immunophenotyping. Leukemia and Lymphoma, 22, 187-204.
2. Bauchinger, M. & Mezger, J. (1990) A case of malignant mastocytosis with near-haploid, near-diploid, and polyploid cells in the bone marrow. Cancer Genetics and Cytogenetics, 48, 13-21.
3. Beghini, A., Cairoli, R., Morra, E. & Larizza, L. (1998) In vivo differentialion of mast cells from AML M2 blasts carrying a novel activating ligand-independent c-kit mutation. British Journal of Haematology, 102, 1-3.
4. Brunning, R.D., Parkin, J.L., McKenna, R.W., Risdall, R. & Rosai, J. (1983) Systemic mastocytosis: extracutaneous manifestations. American Journal of Surgical Pathology, 7, 425-438.
5. Butterfield, J.J., Weiler, D., Dewald, G. & Gleich, G.J. (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Research, 12, 345-355.
6. Casassus, Ph., Lortholary, O., Caillat-Vigneron, N., Launay, J.M., Laroche, L., Gallaio, V., Simon, J., Le Roux, G., Lortholary, P., Guillevin, L. & Raphaël, M. for the GEMASS (1996) Systemic mastocytosis (SM) can be attenuated with interferon-α (IFN-α): prospective analysis of 10 patients. (Abstract). Blood, 88, (Suppl. 1). 203B.
7. Dalton, R., Chan, L., Batten, E. & Eridani, S. (1986) Mast cell leukaemia: evidence for bone marrow origin of the pathological clone. British Journal of Haematology, 64, 397-406.
8. Dash, S., Rao, N.R., Deodhar, S.D. & Varma, N. (1991) Malignant mastocytosis and myelodysplastic syndrome. British Journal of Haematology, 79, 530-531.
9. Erber, W.N., Asbahr, H., Rule, S.A. & Scott, C.S. (1994) Unique immunophenotype in acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies. British Journal of Haematology, 88, 101-104.
10. Escribano, L., Orfao, A., Diaz-Agustin, B., Villarrubia, J., Cerveró, C., López, A., Garcia Marcos, M.A., Bellas, C., Fernandez-Canadas, S., Cuevas, M., Sánchez, A., Velasco, J.L., Navarro, J.L. & San Miguel, J.F. (1998) Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood, 91, 2731-2736.
11. Fallon, M.D., Whyte, M.P. & Teitelbaum, S.L. (1981) Systemic mastocytosis associated with generalized osteopenia. Human Pathology, 12, 813-820.
12. Fanning, S.F., White, M.J., Douglas, J.B. & Rowell, J.A. (1992) Systemic heparin-like activity in mastocytosis. Australian and New Zealand Journal of Medicine, 22, 170-171.
13. Frieri, M., Alling, D.W. & Metcalfe, D.D. (1985) Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: results of a double-blind clinical trial. American Journal of Medicine, 78, 9-14.
14. Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Suguhara, H., Butterlield, J.H., Ashman, L.K., Kanayama, Y., Matsuzawa, Y., Kitamura, Y. & Kanakura, Y. (1993) Identification of mutations in the coding sequences of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. Journal of Clinical Investigation, 92, 1736-1744.
15. Golkan, I. & Nernhard, J.D. (1997) Mastocytosis. Lancet, 349, 1379-1385.
16. Grundfest, S., Cooperman, A.M., Ferguson, R. & Benjamin, S. (1980) Portal hypertension associated with systemic mastocytosis and splenomegaly. Gastroenterology, 78, 370-373.
17. Horny, H.J.P., Ruck, M., Wehrmann, M. & Kaiserling, E. (1990) Blood findings in generalized mastocystosis: evidence of frequent simultaneous occurrence of mycloproliferative disorders. British Journal of Haematology, 76, 186-193.
18. Horny, H.-P., Kaiserling, E., Campbell, M., Parwaresch, M.R. & Lennert, K. (1989) Liver findings in generalized mastocytosis: a clinicopathologic study. Cancer, 63, 532-538.
19. Horny, H.-P., Parwaresch, M.R. & Lennert, K. (1985) Bone marrow findings in systemic mastocytosis. Human Pathology, 16, 808-814.
20. Horny, H.-P., Sillaber, C., Menke, D., Kaiserling, E., Wehrmann, M., Stehberger, B., Chott, A., Lechner, K., Lennert, K. & Valent, P. (1998) Diagnostic value of immunostaining for tryptase in patients with mastocytosis. American Journal of Surgical Pathology, 22, 1132-1141.
21. Hübner, C., Wedding, U., Sträter, J., Limburg, B. & Stremmel, W. (1997) Clinical stable systemic mastocytosis with interferon alpha-2b therapy. Journal of Internal Medicine, 241, 529-533.
22. Kitayama, H., Tsujimura, T., Matsumura, I., Oritani, K., Ikeda, H., Ishikawa, J., Okabe, M., Suzuki, M., Yamamura, K.-L., Matsuzawa, Y., Kitamura, Y. & Kanakura, Y. (1996) Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tryosine kinase. Blood, 88, 995-1004.
23. Kluin-Nelemens, H.C., Jansen, J.H., Breukelman, H., Wolthers, B.G., Kluin, P.M., Kroon, H.M. & Willemze, R. (1992) Response to interferon alpha-2b in a patient with systemic mastocytosis. New England Journal of Medicine, 326, 619-623.
24. Krober, S.M., Horny, H.-P., Ruck, P., Kammerer, U., Geiselhart, A., Handgretinger, R., Griessser., H., Mewnke, D.M. & Keiserling, E. (1997) Mastocytosis: reactive or neoplastic? Journal of Clinical Pathology, 50, 525-527.
25. Krsnik, L., Ricard, M.P., Escribano, L.M., Calero, M.A., Perez Rus, G., Garcia Suarez, J., Perera, F. & Merino, J.L. (1991) Systemic mastocytosis and primary thrombocythaemia. British Journal of Haematology, 77, 437.
26. Kyriakou, D., Kouroumalis, E., Konsolas, J., Oekonomaki, H., Tzardi, M., Kanavaros, P., Manoussos, O. & Eliopoulos, G.D. (1998) Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis: report of four cases. American Journal of Gastroenterology, 93, 106-108.
27. Labar, B., Mrsić, M., Boban, D., Batinić, D., Marković-Glamočak, M., Hitrec, V., Seiwerth, S., Davidović-Mrsić, S. & Serventi-Seiwerth, R. (1994) Acute mastocytic leukaemia: case report. British Journal of Haematology, 87, (Suppl. 1), 13.
28. Lennert, K. & Parwaresch, M.R. (1979) Mast cells and mast cell neoplasia: a review. Histopatholgoy, 3, 349-365.
29. Le Tourneau, A., Gaulard, P., D'Agay, M.F., Vainchencker, W., Cadiou, M., Devidas, A., Haioun, C., Clauvel, J.P., Adouin, J. & Diebold, J. (1991) Primary thrombocythaemia associated with systemic mastocytosis. British Journal of Haematology, 79, 84-89.
30. Lewis, J.P. Welborn, J.L., Meyers, F.J., Levy, N.B. & Rosehak, T. (1987) Mast cell disease followed by leukemia with clonal evolution. Leukemia Research, 11, 769-773.
31. Li, C-Y. & Yam, L.T. (1987) Cytochemical characterization of leukemic cells with numerous cytoplasmic granules. Mayo Clinic Proceedings, 62, 978-985.
32. Li, C-Y & Yam, L.T. (1994) Cytochemistry and immunochemistry in hematologic diagnoses. Hematology/Oncology Clinics of North America, 8, 665-681.
33. Lishner, M., Confino-Cohen, R., Mckori, Y.A., Feigin, M., Manor, Y., Goldberg, A., Ravid, M. & Amiel, M. (1996) Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. Journal of Allergy and Clinical Immunology, 98, 199-204.
34. Liso, V., Troccoli, G. & Specchia, G. (1978) Mast cell leukemia and acute basophilic leukemia. Hematologica, 45, 142-146.
35. Longley, B.J., Tyrrell, L., Lu, S-Z., Ma, Y-S., Langley, K., Deny, T-g., Duffy, T., Jacobs, P., Tang, L.H. & Modlin, I. (1996) Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature Genetics, 12, 312-314.
36. Mehta, A.B., Bain, B.J., Fitchett, M., Shab, S. & Secker-Walker, L.M. (1998) Trisomy 13 and myeloid malignancy: characteristic blast cell morphology. A United Kingdom Cancer Cytogenetics Group Survey. British Journal of Haematology, 101, 749-752.
37. Metcalfe, D.D. (1991) Clinical advances in mastocytosis. Conclusions. Journal of Investigative Dermatology, 96, 64s-65s.
38. Mezger, J., Permanetter, W., Gerhartz, H., Bartl, R., Bauchinger, M., Schmetzer, H. & Sauer, H. (1990) Philadelphia chromosome-negative acute hemopoietic malignancy: ultrastructural, cytochemical and immunocytochemical evidence of mast cell and basophil differentiation. Leukemia Research, 14, 169-175.
39. Mican, J.M., de Bisceglie, A.M., Fong, T.-L., Travis, W.D., Kleiner, D.E., Baker, B. & Metcalfe, D.D. (1995) Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases. Hepatology, 22, 1165-1177.
40. Nagata, H., Worobec, A.S., Oh, C.K., Chowdhury, B.A., Tannenbaum, S. & Metcalfe, D.D. (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proceedings of the National Academy of Sciences of the United Stales of America, 93, 10560-10564.
41. Parker, R.I. (1991a) Hematologic aspects of mastocytosis. I. Bone marrow pathology in adult and pediatric systemic mast cell disease. Journal of Investigative Dermatology, 96, (Suppl.), 47s-51s.
42. Parker, R.I. (1991b) Hematologic aspects of mastocytosis. II. Management of hematologic disorders in association with systemic masl cell disease. Journal of Investigative Dermatology, 96, (Suppl.), 52s-54s.
43. Parkin, J.L., McKenna, R.W. & Brunning, R.D. (1982) Philadelphia-positive blastic leukaemia: ultrastructural and ultracytochemical evidence of basophil and mast cell differentiation. British Journal of Haematology, 52, 663-677.
44. Peterson, L.C., Parkin, J.L., Arthur, D.C. & Brunning, R.D. (1991) Acute basophilic leukaemia: a clinical, morphologic and cytogenetic study of eight cases. American Journal of Clinical Pathology, 96, 160-170.
45. Pignon, J-M., Giraudier, S., Duquesnoy, P., Jouault, H., Imbert, M., Vainchenker, W., Vernant, J-P. & Tulliez, M. (1997) A new c-kit mutation in a case of aggressive mast cell disease. British Journal of Haematology, 96, 374-376.
46. Polli, N., O'Brien, M., Tavares de Castro, J., Matutes, E., San Miguel, J.F. & Catovsky, D. (1985) Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. British Journal of Haematology, 59, 277-296.
47. 2 in patients with systemic mastocytosis. New England Journal of Medicine, 303, 1400-1404.
48. Rödjer, S., Roupe, G., & Sowlin, G. (1996) Bone marrow chromosomes in systemic mastocytosis. British Journal Haematology, 93, Suppl. 2, 332.
49. Rylwin, A.M., Hoffman, E.P. & Ortega, R.S. (1972) Eosinophilic fibrohistiocytic lesions in bone marrow: a distinctive new morphologic finding probably related to drug hypersensitivity. Blood, 40, 464-472.
50. Schmiegelow, K. (1990) Philadelphia chromosome-negative acute hemopoietic malignancy: ultrastructural, cytochemical and immunocytochemical evidence of mast cell and basophil differentiation. European Journal of Haematology, 44, 74-77.
51. Shekter-Levin, S., Ball, E., Swerdlow, S.H., Li, W.V., Kapadia, S.B., Sherer, M.E., Wald, N. & Gollin, S.M. (1998) A near-haploid bone marrow in systemic mast cell disease: is it characteristic of the disease or an incidental finding? Cancer Genetics and Cytogenetics, 103, 124-129.
52. Soler, J., O'Brien, M., Tavares de Castro, J., San Miguel, J.F., Kearney, L., Goldman, J.M. & Catovsky, D. (1985) Blast crisis of chronic granulocytic leukemia with mast cell and basophil precursors. American Journal of Clinical Pathology, 83, 254-259.
53. Soter, N.A., Austen, F. & Wasserman, S.I. (1979) Oral disodium cromoglycate in the treatment of systemic mastocytosis. New England Journal of Medicine, 301, 465-469.
54. Swolin, B., Rodjer, S. & Roupe, G. (1987) Cytogenetic studies and in vitro colony growth in patients with mustocytosis. Blood, 70, 1928-1932.
55. Topar, G., Staudacher, C., Geisen, F., Gabl F., Fend, F., Herold, M., Greil, R., Fritsch, P. & Sepp, N. (1998) Urticaria pigmentosa: a clinical, hematologic, and serologic study of 30 adults. American Journal of Clinical Pathology, 109, 279-285.
56. Tavis, W.D., Li, C-Y., Bergstralh, E.J., Yam, L.T. & Swee, R.G. (1988a) Systemic mast cell disease: analysis of 58 cases and literature review. Medicine, 67, 345-368.
57. Travis, W.D., Li, C-Y., Hoagland, H.C., Travis, L.B. & Banks, P.M. (1986) Mast cell leukemia: report of a case and review of the literature. Mayo Clinic Proceedings, 61, 957-966.
58. Travis, W.D., Li, C-Y., Yam, L.T., Bergstralh, E.J. & Swee, R.G. (1988b) Significance of systemic mast cell disease with associated haematologic diagnosis. Cacer 62, 965-972.
59. Valent, P. (1995) Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes. European Journal of Clinical Investigation, 25, 715-720.
60. Valent, P., Spanblöchl, E., Bankl, H.C., Sperr, W.R., Marosi, C., Pirc-Donvewinata, H., Virgolini, I., Eichler, H.G., Agis, H., Sillaber, C., Bettelheim, P. & Lechner, K. (1994) Kit ligand/mast cell growth factor-indepndent differentiation of mast cells in myelodysplasia and chronic myeloid leukernia blast crisis. Blood, 84, 4322-4332.
61. Webb, T.A., Chin-Yang, L. & Yam, L.T. (1982) Systemic mast cell disease: a clinical and haematopathologic study of 26 cases. Cancer, 49, 927-938.
62. Worobec, A.S., Kirshenbaum, A.S., Schwartz, L.B. & Metcalfe, D.D. (1996) Treatment of three patients with systemic mastocytosis with interferon alpha-2b. Leukemia and Lymphoma, 22, 501-508.
63. Zhang, Y., Schlegelberger, B., Weber-Matthiesen, K., Grote, W. & Bartels, H. (1994) Translocation (X;8) (q2?6;q21.3) in a case of systemic mastocytosis. Cancer Genetics and Cytogenetics, 78, 236-241.